Levi & Korsinsky Urges Primo Brands Corporation / Primo Water Corporation (PRMB) Shareholders to Act Before Lead Plaintiff Deadline January 12, 2026November 14, 2025 3:55 PM EST | Source: Levi & Korsinsky, LLPNew York, New York--(Newsfile Corp. - November 14, 2025) - If you suffered a loss on your Primo Brands Corporation / Primo Water Corporation (NYSE: PRMB) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:h ...

Core Viewpoint - A class action securities lawsuit has been filed against MoonLake Immunotherapeutics, alleging securities fraud that affected shareholders between March 10, 2024, and September 29, 2025 [2][3]. Group 1: Lawsuit Details - The lawsuit claims that the defendants made false statements regarding their drug candidate SLK, asserting that it shares molecular targets with BIMZELX and that SLK's unique Nanobody structure does not provide superior clinical benefits [3]. - Allegations include that SLK's supposed increased tissue penetration would not lead to improved clinical efficacy, and thus the defendants lacked a reasonable basis for their positive claims about SLK's superiority over traditional monoclonal antibodies [3]. Group 2: Next Steps for Shareholders - Shareholders who experienced losses during the specified timeframe are encouraged to seek information on their rights to recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP, a well-established securities litigation firm, has a strong track record in securing recoveries for shareholders and has been recognized as one of the top securities litigation firms in the United States [5].

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. for alleged securities fraud affecting shareholders between August 6, 2024, and August 4, 2025 [2]. Group 1: Lawsuit Details - The lawsuit claims that the company made false statements regarding the launch of its new product, Inspire V, which was reportedly unsuccessful due to poor demand and excess inventory at treatment centers [3]. - Allegations include that Inspire Medical Systems failed to complete essential tasks for a successful product launch, such as training for treatment center customers, setting up IT systems, and ensuring proper Medicare reimbursement [3]. Group 2: Next Steps for Affected Shareholders - Shareholders who experienced losses during the specified timeframe are encouraged to seek information on their rights to recovery, with no cost or obligation to participate [4]. Group 3: Legal Representation - Levi & Korsinsky LLP, a recognized securities litigation firm, has a history of securing significant recoveries for shareholders and has been ranked among the top securities litigation firms in the U.S. for seven consecutive years [5].

Core Viewpoint - A class action securities lawsuit has been filed against CarMax, Inc. alleging securities fraud that affected shareholders between June 20, 2025, and September 24, 2025 [2][3] Group 1: Lawsuit Details - The lawsuit claims that CarMax's management made false statements regarding the company's growth prospects, suggesting that the growth in the 2026 fiscal year was misleadingly attributed to temporary factors such as customer speculation about tariffs [3] - The complaint asserts that the statements made by the defendants about CarMax's business operations and future prospects were materially false and lacked a reasonable basis during the relevant time [3] Group 2: Next Steps for Affected Shareholders - Shareholders who experienced losses in CarMax stock during the specified period are encouraged to seek information about their rights to recovery, with no cost or obligation to participate [4] Group 3: Legal Representation - Levi & Korsinsky LLP, a recognized securities litigation firm, has a strong track record of securing significant recoveries for shareholders and has been ranked among the top securities litigation firms in the United States for seven consecutive years [5]

Core Viewpoint - A securities fraud class action has been filed against Synopsys, Inc. following disappointing Q3 2025 financial results, which were attributed to underperformance in its IP business [1][2]. Group 1: Legal Action and Investigation - The class action lawsuit seeks to represent investors who acquired Synopsys securities between December 4, 2024, and September 9, 2025 [1][3]. - The lawsuit was prompted by a significant drop in Synopsys' share price, which fell by $216.59, or 35%, on September 10, 2025, after the company reported poor financial results [2][5]. - Hagens Berman, a national shareholders rights firm, is investigating claims that Synopsys misled investors regarding customer risks and growth prospects [2][6]. Group 2: Financial Performance - Synopsys reported Q3 2025 earnings per share (EPS) of $1.50, representing a 45% decline year-over-year and a 33% decline sequentially [5]. - The company experienced nearly an 8% decline in Design IP revenues compared to the prior year quarter [5]. - The results led to the largest single-day percentage decline in Synopsys' stock since its IPO in 1992 [5]. Group 3: Business Operations and Strategy - Synopsys operates in two reportable segments: Design IP and Design Automation [3]. - The lawsuit alleges that Synopsys made false statements and failed to disclose critical information about its business, particularly regarding the impact of increased focus on AI customers on the economics of its Design IP business [4][5]. - The company acknowledged the need to pivot its IP resources and roadmap to focus on the highest-growth opportunities [5].

Core Viewpoint - Halper Sadeh LLC is investigating potential violations of federal securities laws and breaches of fiduciary duties related to the sales of TreeHouse Foods, Inc. and Gulf Island Fabrication, Inc. [1][2] Group 1: TreeHouse Foods, Inc. - TreeHouse Foods, Inc. is being sold to Industrial F&B Investments III Inc. for $22.50 in cash per share, plus a contingent value right [1] - The investigation aims to seek increased consideration for shareholders and additional disclosures regarding the proposed transaction [3] Group 2: Gulf Island Fabrication, Inc. - Gulf Island Fabrication, Inc. is being sold to IES Holdings, Inc. for $12.00 in cash per share [2] - Similar to TreeHouse, the investigation may pursue increased consideration and additional information for shareholders [3] Group 3: Legal Representation - Halper Sadeh LLC offers free consultations for shareholders to discuss their legal rights and options [4] - The firm operates on a contingent fee basis, meaning shareholders would not incur out-of-pocket legal fees [3]

Core Viewpoint - A class action lawsuit has been filed against Primo Brands Corporation and certain officers for alleged violations of federal securities laws related to the merger with BlueTriton Brands [1][3]. Class Definition - The lawsuit seeks damages for all individuals and entities that purchased Primo Water Corporation common stock between June 17, 2024, and November 8, 2024, and Primo Brands Corporation common stock between November 11, 2024, and November 6, 2025 [2]. Case Details - The Complaint alleges that Defendants misrepresented and failed to disclose critical facts about the merger integration process, leading investors to believe in accelerated growth and strong financial results [3]. Next Steps - Investors who suffered losses in Primo have until January 12, 2026, to request to be appointed as lead plaintiff in the case [4]. Legal Representation - The law firm represents investors on a contingency fee basis, meaning they will only collect fees if successful in recovering damages [5]. Firm Background - Bronstein, Gewirtz & Grossman, LLC is a recognized firm specializing in securities fraud class actions and has recovered hundreds of millions for investors [6].

Core Viewpoint - A securities class action lawsuit has been filed against Firefly Aerospace Inc. by Kessler Topaz Meltzer & Check, LLP, alleging that the company made false and misleading statements regarding its business operations and growth prospects [1][2]. Summary by Sections Lawsuit Details - The lawsuit is on behalf of investors who purchased Firefly's common stock during the IPO on August 7, 2025, and those who acquired securities between August 7, 2025, and September 29, 2025 [1]. - The lead plaintiff deadline for the lawsuit is set for January 12, 2026 [1]. Allegations Against Defendants - The complaint claims that Firefly overstated the demand and growth prospects for its Spacecraft Solutions offerings [2]. - It is alleged that the Alpha rocket program did not meet its claimed operational readiness and commercial viability [2]. - As a result of these issues, the statements made by the defendants regarding the company's business and prospects were materially false and misleading [2]. Lead Plaintiff Process - Investors may seek to be appointed as a lead plaintiff representative of the class by the deadline of January 12, 2026, or may choose to remain absent [3]. - The lead plaintiff will represent all class members in directing the litigation and selecting counsel [3]. Firm Background - Kessler Topaz Meltzer & Check, LLP has a reputation for prosecuting class actions and has recovered billions for victims of corporate misconduct [5].

Core Viewpoint - Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Soleno Therapeutics, Inc., focusing on whether the company and its executives made false or misleading statements or failed to disclose material information to investors [1]. Company Overview - Soleno Therapeutics announced FDA approval for VYKAT XR (diazoxide choline) extended-release tablets on March 26, 2025, for treating hyperphagia in individuals aged 4 and older with Prader-Willi syndrome [3]. Recent Developments - During a quarterly earnings call on November 4, 2025, Soleno disclosed that the discontinuation rate of VYKAT XR due to adverse effects was approximately 8% at the end of Q3 2025. The CEO acknowledged a disruption in the product's launch trajectory following a short seller report in mid-August, which led to a decrease in start forms and an increase in discontinuations for non-serious adverse events. Following this announcement, Soleno's share price dropped by over 26% [4].

Accessibility StatementSkip Navigation WHAT'S NEXT? If you suffered a loss in MoonLake during the relevant time frame, you have until December 15, 2025Â to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. NO COST TO YOU: If you are a class member, you may be entitled to compensation without payment of any out-of-pocket costs or fees. There is no cost or obligation to participate. WHY LEVI & KORSINSKY: Over the pas ...